Stallergenes Greer

📍 Baar, Switzerland🗓 Founded 2015👥 1,005 employees💰 Last funded 2014
Pharmaceutical Manufacturing🌐 stallergenesgreer.com
Website LinkedIn
Stallergenes Greer is a global biopharmaceutical company specialising in the diagnosis and treatment of respiratory allergies through the development and commercialisation of Allergy Immunotherapy products and services. Link to our Privacy policy: https://www.stallergenesgreer.com/personal-data-protection-policy Our purpose is to enable precision medicine to improve life for people with allergies. With nearly 1,100 employees worldwide, a presence in 41 countries, and manufacturing facilities in both Europe and the United States, Stallergenes Greer International AG is the parent company of GREER Laboratories, Inc. (whose registered office is in the U.S.) and Stallergenes S.A.S. (whose registered office is in France). With complementary strengths, joint heritage and reputations, Stallergenes Greer is driving a continuing leadership in allergy immunotherapy. Link to our privacy policy: https://www.stallergenesgreer.com/personal-data-protection-policy
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Hong Kong SAR
1
United States
1
Frequently asked questions
Who invested in Stallergenes Greer?
Stallergenes Greer has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Stallergenes Greer last raise funding?
The most recent investment in Stallergenes Greer recorded on gritt.io was in 2014.
When was Stallergenes Greer founded?
Stallergenes Greer was founded in 2015.
What industry is Stallergenes Greer in?
Stallergenes Greer operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is Stallergenes Greer based?
Stallergenes Greer is headquartered in Baar, Switzerland.